Navigation Links
Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation
Date:7/28/2008

roadly the Eligen(R) Technology can be applied and how it serves as a solution to hurdles with difficult to absorb molecules, whether they are prescription drug products or essential minerals and nutrients."

Currently, it's estimated that five million people in the United States are taking 40 million injections of B12 per year to treat a variety of debilitating medical conditions (as noted above). Another estimated five million are consuming more than 600 million tablets of B12 orally.

Emisphere's broad-based delivery technology platform, known as the Eligen(R) Technology, uses proprietary, synthetic chemical compounds, known as Emisphere delivery agents, sometimes called carriers. Emisphere's Eligen(R) Technology makes it possible to deliver a target molecule (vitamin, therapeutic drug, etc.) without altering its chemical form or biological integrity.

CONFERENCE CALL

A teleconference to discuss these data further will be held on Tuesday, July 29, 2008 at 10:00 AM EDT. A live webcast of the conference call can be accessed through the company's Web site at: http://www.emisphere.com. The live conference call dial-in number is: 1-800-895-0198 (United States and Canada) or 1-785-424-1053 (International).

ABOUT EMISPHERE

Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on a unique and improved delivery of target molecules and pharmaceutical compounds using its Eligen(R) Technology. Some of these molecules or compounds can only be given by injection; when combined with our technology; convenient oral versions may be safe, effective and provide significant advantages. The benefits of other compounds are limited due to poor bioavailability, slow on-set of action or variable absorption. In those cases, use of Emisphere's technology can improve the therapeutic effectiveness of the compounds. The Eligen(R) Technology can be applied to the oral route of adminis
'/>"/>

SOURCE Emisphere Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
3. Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology
4. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
5. Proof of Concept Study in Second Species Demonstrates Increase in Absorption of Oral B12 Using Emisphere Technology
6. Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
7. Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
10. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
11. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,Calif.,Nov.24/PRNewswire-FirstCall/--IsisPharmace...erapeutics,todayannouncedthatmanagementwillpresent...reConferenceonTuesday,December1,2009,at10:30a.m.ET...thepresentationwillbeavailableonthe"Investors&...com .AreplayofthepresentationwillbeavailableontheI...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--OptimerPharmaceutic...stAnnualPiperJaffrayHealthCareConferenceatTheNewYo...ternTime. ,, (Logo: http://www.newscom.com/cgi-...bcastofthispresentationwillbeaccessibleontheInvest...com .Replaysofthispresentationwillbeavailableatth...
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--KeryxBiopharmaceutic...r,theCompany,sChiefExecutiveOfficer,isscheduledtop...ncebeingheldinNewYorkCity. ,, Mr.Bentsur,sprese...0:30AMETandwillbeaccessiblefromtheInvestorInformat...ryx.com .Anarchivedversionofthewebcastwillbeavaila...
Breaking Medicine Technology:Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Pivotal White Paper Examines Retail Industrys Critical Role in Reengineering the Health Care System 49716 1Pivotal White Paper Examines Retail Industrys Critical Role in Reengineering the Health Care System 49716 2Pivotal White Paper Examines Retail Industrys Critical Role in Reengineering the Health Care System 49716 3CutisPharma Inc Receives Verified Accreditation for Wholesale Distributors from the National Association of Boards of Pharmacy for Woburn Facility 12737 1CutisPharma Inc Receives Verified Accreditation for Wholesale Distributors from the National Association of Boards of Pharmacy for Woburn Facility 12737 2Medcos Advanced Pharmacy Adds 162 New Jobs for Total of 1 400 49713 1Medcos Advanced Pharmacy Adds 162 New Jobs for Total of 1 400 49713 2Medcos Advanced Pharmacy Adds 162 New Jobs for Total of 1 400 49713 3
...aq: BNVI ) announced today that its drug candidat...ce to Phase 2 clinical testing after the,successfu... The Phase 1B clinical trial was conducted to iden...etermine the safety and feasibility of the,company...7 women with,metastatic breast cancer were enrolle...
...obes can block nitric,oxide production - a chemica...fighting bacteria, MEMPHIS, Tenn., Nov. 3 St. Ju...scovered a mechanism by which,intracellular pathog...eapons against them: nitric oxide. The researchers...tion by subverting the biochemical machinery used,...
Other Medicine Technology:Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 2Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 3Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 4Parasites That Live Inside Cells Use Loophole to Thwart Immune System 2Parasites That Live Inside Cells Use Loophole to Thwart Immune System 3
(Date:11/24/2009)...24/PRNewswire-FirstCall/--CenteneCorporation(NYSE:...dicaidhasselectedCenteneasoneoftwoCoordinatedCareO...edAccessNetwork(MississippiCAN),acoordinatedcarepr...workingwiththeDivisiontoexecuteacontractinwhichthe...asMagnoliaHealthPlan(Magnolia). ,, BasedinJacks...
(Date:11/24/2009)...se choking hazard, are too loud, or contain danger...thDay News) -- As the holiday shopping season begi...are still being sold in stores across the United S...al Trouble in Toyland report, released Tuesday b..., The report focuses on toys that pose a chokin...
(Date:11/24/2009)...es didn,t differ greatly between high- and low-vol...v. 24 (HealthDay News) -- Do hospitals that conduc...est results for patients? Maybe not. , Prior re... when it comes to artery-opening procedures, but a...w- and high-volume hospitals performing more or le...
(Date:11/24/2009)...rchers have found that hormones produced during pr...e growth of breast cancer. This protein, alpha-fet...ted agent for the treatment and prevention of brea...cer Prevention Research , a journal of the America...in pregnancy, such as estrogen, all induce AFP, wh...
(Date:11/24/2009)...mple, study finds no added use but higher costs ,...irect-to-consumer drug ads may contribute to highe...amined sales of the widely used antiplatelet drug ...om 1999 to 2005 for 27 state Medicaid programs fou...grel did not increase people,s use of the drug but...
Breaking Medicine News(10 mins):Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 3Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Protein from pregnancy hormone may prevent breast cancer 2Health News:Advertising to Consumers May Raise Drug Prices 2
...drivers take their eyes off the road to find their...tc.) and then they look to see who's calling....r eyes off the road to scroll through their contac...age or to write down a voice mail and return the c...
...s,Inc., has been sold to Assurance Investment Part... Cross and Blue Shield in Kentucky, Arison has six..., life and disability,insurance to groups and indi...nderson, who served as vice president, will replac...
...ast Cancer Survivor Shares Her Experienc...y 1 Susan G. Komen for the Cure(R) today,announce... Arrington has,pledged her support in the battle a...t breast cancer. As a breast,cancer survivor, Arri...
...T CREEK, Calif., July 1 Longs Drug,Stores Corpora...ntinue to,honor new and refilled prescriptions for...ate,s plan to cut reimbursements effective July 1....Medicaid (Medi-Cal) reimbursements. Because under ...
...of the,nation,s leading distributors of diabetic t...g diabetics to continue to receive their testing s...ive bidding program, effective,today., The progra...upply was selected by The Centers for Medicare & M...
...gestions to help with s...r vacations are in full,swing and travelers are pa...big question is what should they bring to help wit... "Homeopathic products are great for everyone; pa...
Other Medicine News:Health News:Lake Forest, CA: SpeechPhone Launches Handsfree Driving Solution Just in Time to Comply with New Handsfree Driving Laws 2Health News:Lake Forest, CA: SpeechPhone Launches Handsfree Driving Solution Just in Time to Comply with New Handsfree Driving Laws 3Health News:Assurance Investment Partners Purchases Arison Insurance Services from Anthem Blue Cross and Blue Shield 2Health News:Syndicated Radio Personality Ebony 'Steele' Arrington Continues the Fight Against Breast Cancer as National Ambassador for Susan G. Komen for the Cure(R)'s Circle of Promise 2Health News:Syndicated Radio Personality Ebony 'Steele' Arrington Continues the Fight Against Breast Cancer as National Ambassador for Susan G. Komen for the Cure(R)'s Circle of Promise 3Health News:Longs Drug Stores to Continue to Service Medi-Cal Patients 2Health News:Longs Drug Stores to Continue to Service Medi-Cal Patients 3Health News:Doctor Diabetic Supply Helps Diabetics to Receive Their Testing Supplies as Medicare's Competitive Bidding Program Starts 2Health News:Homeopathic First Aid Kit: Solutions for Summer's Little Bummers 2Health News:Homeopathic First Aid Kit: Solutions for Summer's Little Bummers 3
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: